Spotlight February 2021: Nanoobjects in the COVID-vaccine – scientifically correct?

Home > Spotlight February 2021: Nanoobjects in the COVID-vaccine – scientifically correct?

The COVID-19 pandemic induces very different reactions of people on the internet (https://www.cdc.gov/mmwr/volumes/70/wr/mm7002e1.htm) and in the social networks. Without following the conspiracy theories as “5G nanochip hidden in COVID vaccines” some news as “COVID vaccines induce allergic reactions” should be scientifically recognised. The picture from the 5G-nanochip whose plan goes viral on the internet is now exposed as fake and shows a guitar pedal. Quite different the recent news about allergic responses after injection of the COVID vaccine [1-3]. Is it true, and how about nanoparticles in vaccines?

Firstly, we should know that the active ingredient within the new vaccines are very sensitive molecules (the so-called mRNA) which must not only be cooled during transport but also would immediately be degraded after injection if not explicitly be stabilized by a special nano-shell. Here the principles of nanomedicine are adopted as the instable RNA-molecule is packed into a lipid layer containing stabilizing polymers (e.g. polyethylene glycol = PEG and others) [4, 5]. These polymers are part of the transport system which delivers the active agent to the cells in our body which start the anti-viral machinery. Unfortunately, such molecules may have a disadvantage because a small part of the population responds sensitive to polymers such as PEG which has been observed in 12 patients after getting the vaccine [1, 3]. The portion of sensitive people is very small but not negligible (currently more than 32 Mio. people have been vasccinated, as of January 2021), thus, it is important to know about the ingredients [please find the full list of the two recent vaccines in 3] and to discuss these with the treating physician. Scientific fact is: the size of the lipid vesicles (nano) is not of importance in relation to adverse effects. Ingredients such as the polymers of the shell around the active agent may induce problems, but the advantage of a COVID vaccination is indisputable.

If someone wants to know more about nanoparticles and vaccination, please visit the website of the Helmholtz Centre for Infection Research: https://www.helmholtz-hzi.de/en/news-events/stories/vaccination-with-nanoparticles/ .

 

Literature:

  1. de Vrieze, J (2021)  Pfizer’s vaccine raises allergy concerns. Science, 371(6524): 10-11.
  2. Kleine-Tebbe, J et al. (2021) Severe allergic reactions to the COVID-19 vaccine – statement and practical consequences. Allergol Select, 5 26-28.
  3. Worm, M et al. (2021) Covid-19 vaccination and risk of anaphylaxis – Recommendations for practical management. MMW Fortschr Med, 163(1): 48-51.
  4. Editorial (2020) Nanomedicine and the COVID-19 vaccines. Nat Nanotechnol, 15(12): 963
  5. Abd Ellah, NH et al. (2020) Nanomedicine as a promising approach for diagnosis, treatment and prophylaxis against COVID-19. Nanomedicine (Lond), 15(21): 2085-2102.
Spotlight February 2021: Nanoobjects in the COVID-vaccine – scientifically correct?

Weitere Spotlights


Spotlight November 2020: Nanotechnology in the public perception

Spotlight November 2020: Nanotechnology in the public perception

In November, we would like to draw your attention to a publication that examines public perception of the safety of nanomaterials in Austria.It shows, that although there is generally a rather positive attitude towards nanomaterials, there are different opinions on safety issues from different social groups. Further clarification seems necessary. Despite the widespread use of […]

Read more

Spotlight October 2020: Nanosafety – Topic of the Future

Spotlight October 2020: Nanosafety – Topic of the Future

Research on nanosafety is a driver of innovation as the spotlight in July has demonstrated. But furthermore, this research field is built on routine as well if researchers look for the “needle in the haystack”. In many areas the safety research initiates the development of new methods, e.g. for the determination of nanoparticles within exposed organisms via […]

Read more

Spotlight December 2020: Rethinking Nanosafety – Part II

Spotlight December 2020: Rethinking Nanosafety – Part II

In December we would like to draw attention to the special issue: Rethinking Nanosafety – Part II in small. In the July Spotlight we already presented Part I. This special issue “Rethinking Nanosafety – Part II” also features research papers by renowned scientists in the field of nanosafety research. The first part of this special […]

Read more

Spotlight May 2021: Towards safe and sustainable innovation in nanotechnology: State-of-play for smart nanomaterials

Spotlight May 2021: Towards safe and sustainable innovation in nanotechnology: State-of-play for smart nanomaterials

The European Commission’s new Action Plan for a Circular Economy Green Deal, the new European Industrial Strategy as well as the Chemicals Strategy for Sustainability presented in October 2020 are ambitious plans to achieve a sustainable, fair and inclusive economy in the European Union. These strategies require that any new material or product must not […]

Read more

Skip to content